Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

COSMETIC: OUTCOMES ARTICLE

Evaluation of Variable-Dose Treatment with a New U.S. Botulinum Toxin Type A (Dysport) for Correction of Moderate to Severe Glabellar Lines: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Kane, Michael A. C. M.D.; Brandt, Fredric M.D.; Rohrich, Rod J. M.D.; Narins, Rhoda S. M.D.; Monheit, Gary D. M.D.; Huber, M Barbara B.A. The Reloxin Investigational Group

Author Information
Plastic and Reconstructive Surgery: November 2009 - Volume 124 - Issue 5 - p 1619-1629
doi: 10.1097/PRS.0b013e3181b5641b
  • Buy

Abstract

©2009American Society of Plastic Surgeons